These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19691099)

  • 1. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes.
    Damgé C; Socha M; Ubrich N; Maincent P
    J Pharm Sci; 2010 Feb; 99(2):879-89. PubMed ID: 19691099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
    Socha M; Sapin A; Damgé C; Maincent P
    Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
    Damgé C; Maincent P; Ubrich N
    J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW
    Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
    Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
    Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
    Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
    J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
    Cui F; Shi K; Zhang L; Tao A; Kawashima Y
    J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin aspart(NN-X14)].
    Namba M
    Nihon Rinsho; 2001 Nov; 59(11):2144-50. PubMed ID: 11712399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
    Yang J; Sun H; Song C
    Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
    Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
    Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
    Reis CP; Veiga FJ; Ribeiro AJ; Neufeld RJ; Damgé C
    J Pharm Sci; 2008 Dec; 97(12):5290-305. PubMed ID: 18384153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
    Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
    J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.